LEYBURN MEDICAL PRACTICE
BRENTWOOD, LEYBURN
CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2005 | 255 | 275 | 92.7% | |
| CHD 9 | 2006 | 248 | 263 | 94.3% | |
| CHD 9 | 2007 | 258 | 275 | 93.8% | |
| CHD 9 | 2008 | 257 | 277 | 92.8% | |
| CHD 9 | 2009 | 255 | 274 | 93.1% | |
| CHD 9 | 2010 | 252 | 270 | 93.3% | |
| CHD 9 | 2011 | 241 | 260 | 92.7% | |
| CHD 9 | 2012 | 248 | 266 | 93.2% | |
| CHD 9 | 2013 | 246 | 257 | 95.7% | |
| CHD005 | 2014 | 235 | 238 | 98.7% | |
| CHD005 | 2015 | 228 | 236 | 96.6% | |
| CHD005 | 2016 | 215 | 219 | 98.2% | |
| CHD005 | 2017 | 226 | 233 | 97.0% | |
| CHD005 | 2018 | 237 | 242 | 97.9% | |
| CHD005 | 2019 | 238 | 243 | 97.9% | |
| CHD005 | 2020 | 231 | 240 | 96.2% | |
| CHD005 | 2021 | 234 | 238 | 98.3% | |
| CHD005 | 2022 | 253 | 260 | 97.3% | |
| CHD005 | 2023 | 253 | 259 | 97.7% |
